Global and Local Strategies Intersect at BIO Asia-Taiwan 2026 Plenary on Medicine Resilience
Achieving true medicine resilience requires a fundamental shift from short-term cost savings to a value-driven ecosystem supported by predictable pricing, regulatory flexibility, and strong cross-border partnerships. By embracing these proactive strategies, stakeholders can ensure that patients enjoy steady access to essential medications and breakthrough therapies in an increasingly volatile global market. (Image: GeneOnline)
On July 15, the 2026 BIO Asia-Taiwan International Conference kicked off in Taipei, uniting global biopharma elites to address pressing challenges in modern healthcare. A major highlight of the opening day was the plenary session themed “Medicine Resilience: Global & Local Perspectives”. This session, one of three featured plenaries, brought together voices from public administration, … Global and Local Strategies Intersect at BIO Asia-Taiwan 2026 Plenary on Medicine Resilience Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Syndax Pharmaceuticals CMO Nick Botwood Outlines Leadership Standards for R&D Organizations
2026-08-13
Regeneron Oncology Marketing Lead Sarah Ghosh Details Strategy for Adapting Global Pharmaceutical Narratives
2026-08-13
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




